Reply to: 'Beta-blockers for subarachnoid hemorrhage: When should we use them?'

Neurocrit Care. 2020 Dec;33(3):853-854. doi: 10.1007/s12028-020-01129-5. Epub 2020 Oct 19.

Authors

Aravind V Ramesh¹, Matt Thomas²

Affiliations

¹ Department of Intensive Care, North Bristol NHS Trust, Bristol, UK. [email protected].
² Department of Intensive Care, North Bristol NHS Trust, Bristol, UK.

PMID: 33078346
DOI: 10.1007/s12028-020-01129-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Antagonists / adverse effects
Calcium Channel Blockers / therapeutic use
Humans
Subarachnoid Hemorrhage* / drug therapy

Substances

Adrenergic beta-Antagonists
Calcium Channel Blockers